Comparement of the results diabetic vitrectomy in phakic and non-phakic patients Fakik ve Fakik Olmayan hastaların Diyabetik Vitrektomi sonuçlarının karşılaştırılması

© 2015 Gazi Eye Foundation. All Rights Reserved.Purpose: To evaluate the effect of lens status after pars plana vitrectomy on postoperative results of patients underwent pars plana vitrectomy for vitreous hemorrhage due to diabetes mellitus. Materials and Methods: Records of the patiens who underwent pars plana vitrectomy for vitreous hemorrhage due to diabetes mellitus were studied retrospectively. Twenty-one patients who were phakic before pars plana vitrectomy were accepted as group1, 17 patients who were non-phakic before pars plana vitrectomy were accepted as group 2. Groups were compared based on age, gender, mean follow-up time, final visual acuity, intraoperative complications, improvement in visual acuity, postoperative anterior and posterior complications, reoperation rate and anatomic success. Results: There was no difference between groups regarding age, gender and mean follow-up time. Intraoperative complications occurred in 2 patients (9.1%) of group 1, and 1 patient (5.8%) of group 2. Postoperative complications was seen in 3 patients (13.6%) of group 1, and 2 patients (11.7%) of group 2. Anterior segment complications developed in 5 patients (23.8%) in group1 and 6 patients (29.4%) in group 2. Improvement of visual acuity was achieved in 17 patients (77.8%) of group 1 and 14 patients (82.3%) of group 2 (p=0.624). Reoperation was performed in 2 patients (9.5%) of group 1 and 2 patients (11.7%) of group 2. Conclusion: There was no significant effect of lens status on postoperative results in patients had pars plana vitrectomy surgery for vitreous hemorrhage due to diabetes mellitus

Incidence of endophthalmitis following the intravitreal injections Intravitreal enjeksiyon Görülme insidansı Sonrası endoftalmi

© 2015 Gazi Eye Foundation. All Rights Reserved.Purpose: To report the incidence of acute postoperative endophthalmitis secondary to intravitreal injections. Materials and Methods: A retrospective review of patients who were followed by a single retinal specialist and treated with intravitreal injections between January 2004 to May 2013. Patients who were referred from other clinics as endophthalmitis were not included. Results: During the study interval, 3925 intravitreal injections were performed in 1054 eyes of 788 patients. The mean number of injection per eye was 3.72±3.43 (Range, 1-22). The mean age of the participants was 67.04±13.55 (Range, 5-94 years). 371 participants (47.1%) were female and 417 participants (52.9%) were male. Mean follow-up was 31.92±22.91 month (Range, 1-144 months). Four endophthalmitis cases were noted over the last 9 years. The overall incidence of endophthalmitis was 0.10% per injection (4 of 3925 injections) and 0.38% per eye (4 of 1054 eyes). Conclusions: Endophthalmitis is a rare but serious complication that may occur after any intravitreal injection. To reduce its incidence, clinics should evaluate their own data and elucidate the risk factors